Answers are grounded in this paper and cite their sources.
The application of iron oxide nanoparticles (IONPs) in the biomedical sector has been explored comprehensively, especially in drug delivery systems. However, the limitations of IONPs related to their agglomeration tendency and instability due to oxidation are still the main problems in applying IONPs practically. Surface modification of IONPs using a polymer as a capping layer is an excellent solution that has recently been developed to overcome these problems. In this review, we try to compile the information and extract plausible strategies to obtain a highly efficient polymer capping layer for IONPs, especially in supporting their applications in drug delivery systems. The discussion starts with the basic introduction of IONPs and the polymer capping layer, as well as the synthesis mechanism of polymer-stabilized IONPs. The polymer characteristics that highly contributed to the physical and chemical characteristics of polymer-stabilized IONPs are described. The future steps to enhance specificity targeting and efficacy in drug delivery are also explained, together with the exploration of targeting molecules or ligand-assisted IONPs attachment to the specific receptor, continued by drug release to the cells, is also discussed comprehensively. We expect that our review can pave the way for the implementation of polymer-stabilized IONPs in targeted drug delivery systems for various drugs in the field of cancer treatment and infection. This study also provides information about the key role of the polymer capping layer for IONPs; thus, we hope that this review article is important not only for laboratory-scale research but also for industrial research-based developments.
No takes yet. Share an insight, caveat, or question.
Rani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: